Valuation Mesa Laboratories, Inc.
Stocks
MLAB
US59064R1095
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Cboe BZX
02:58:46 2026-09-03 pm EDT
|
5-day change | 1st Jan Change | ||
| 130.16 USD | -0.37% |
|
+1.10% | +65.69% |
| Aug. 10 | Mesa Laboratories, Inc., Q1 2027 Earnings Call, Aug 10, 2026 | |
| Aug. 10 | Tranche Update on Mesa Laboratories, Inc.'s Equity Buyback Plan announced on November 10, 2005. | CI |
Company Valuation: Mesa Laboratories, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,337 | 934.1 | 591.9 | 644.8 | 488.5 | 731.1 | - |
| Change | - | -30.14% | -36.64% | 8.93% | -24.23% | 49.66% | - |
| Enterprise Value (EV) | 1,506 | 1,084 | 591.9 | 644.8 | 488.5 | 731.1 | 731.1 |
| Change | - | -27.99% | -45.42% | 8.93% | -24.23% | 49.66% | 0% |
| P/E | 728x | 1,028x | -2.32x | -330x | 73.1x | 59.2x | 39.1x |
| PBR | 3.41x | 2.38x | 4.07x | 4.05x | 2.62x | 3.74x | 3.4x |
| PEG | - | -20x | 0x | 3.3x | -0x | 0.7x | 0.8x |
| Capitalization / Revenue | 7.25x | 4.26x | 2.74x | 2.68x | 1.96x | 2.86x | 2.71x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 2.86x | 2.71x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 11.8x | 10.7x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 12.1x | 11.1x |
| EV / FCF | 0x | 0x | 0x | 0x | 0x | 16.5x | 15.7x |
| FCF Yield | 2.6% | 2.51% | 7.02% | 6.6% | 8.1% | 6.07% | 6.39% |
| Dividend per Share 2 | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 |
| Rate of return | 0.25% | 0.37% | 0.58% | 0.54% | 0.72% | 0.49% | 0.49% |
| EPS 2 | 0.35 | 0.17 | -47.2 | -0.36 | 1.21 | 2.207 | 3.34 |
| Distribution rate | 183% | 376% | -1.36% | -178% | 52.9% | 29% | 19.2% |
| Net sales 1 | 184.3 | 219.1 | 216.2 | 241 | 249.1 | 255.3 | 270.3 |
| EBITDA 1 | 41.16 | 49.68 | 50.5 | 56.74 | 63.49 | 62 | 68.45 |
| EBIT 1 | 37.9 | 45.82 | 50.5 | 51.36 | 58.23 | 60.5 | 65.9 |
| Net income 1 | 1.871 | 0.93 | -254.2 | -1.974 | 6.712 | 13.27 | 21.13 |
| Net Debt | 169 | 150.4 | - | - | - | - | - |
| Reference price 2 | 254.88 | 174.73 | 109.73 | 118.66 | 88.42 | 130.65 | 130.65 |
| Nbr of stocks (in thousands) | 5,246 | 5,346 | 5,394 | 5,434 | 5,525 | 5,596 | - |
| Announcement Date | 5/31/22 | 5/25/23 | 6/5/24 | 5/28/25 | 5/27/26 | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 59.21x | - | - | 0.49% | 731M | |
| 31.69x | 4.28x | 16.43x | 2.33% | 191B | |
| 19.8x | 3.57x | 12.75x | 3.17% | 118B | |
| 18.42x | 0.21x | 13.39x | 0.71% | 64.19B | |
| 29.93x | 7.38x | 19.05x | 1.33% | 51.49B | |
| 36.14x | 3.47x | 11.9x | 2.09% | 51.08B | |
| 35.95x | 6.33x | 19.86x | -.--% | 33.85B | |
| 46.86x | 1.34x | 12.44x | 0.2% | 31.85B | |
| 39.96x | 7x | 25.11x | 0.26% | 24.11B | |
| 18.71x | 2.93x | 10.5x | 1.5% | 22.96B | |
| Average | 33.67x | 4.06x | 15.71x | 1.21% | 58.94B | |
| Weighted average by Cap. | 29.03x | 3.91x | 15.30x | 1.84% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- MLAB Stock
- Valuation Mesa Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
